Invesco Ltd. - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,774,131
+15.7%
252,553
+6.8%
0.00%0.0%
Q2 2023$11,039,804
+1446.9%
236,449
+1167.6%
0.00%
Q1 2023$713,664
-93.6%
18,653
-90.8%
0.00%
-100.0%
Q4 2022$11,125,934
+37.4%
203,028
-14.7%
0.00%0.0%
Q3 2022$8,100,000
+5300.0%
237,886
+2147.4%
0.00%
Q1 2022$150,000
-32.1%
10,585
+1.5%
0.00%
Q4 2021$221,000
-15.0%
10,429
-10.5%
0.00%
Q3 2021$260,000
+4.4%
11,656
+16.2%
0.00%
Q2 2021$249,00010,0290.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$169,134,00018.83%
venBio Partners LLC 2,444,311$70,909,0006.74%
Versant Venture Management, LLC 617,727$17,920,0003.49%
Redmile Group, LLC 2,513,746$72,924,0001.03%
Boxer Capital, LLC 831,495$24,122,0000.82%
Integral Health Asset Management, LLC 85,000$2,466,0000.70%
Vivo Capital, LLC 673,280$19,532,0000.69%
SILVERARC CAPITAL MANAGEMENT, LLC 32,000$928,0000.51%
Cormorant Asset Management, LP 742,549$21,541,0000.48%
HHLR ADVISORS, LTD. 1,656,673$48,060,0000.48%
View complete list of AKERO THERAPEUTICS INC shareholders